Resume drafts Unsaved story and dashboard drafts
Comment drafts Unsaved comment drafts
Overview

GSS initially diagnosed as conversion disorder

Date of birth: 1981-01-01
Gender: Female
A woman first presented to neurology in January 2019 with intermittent tremor, dysarthria and psychomotor slowing. Brain MRI, EEG and lumbar puncture were unremarkable, and conversion disorder was diagnosed. Over the following years she developed progressive speech impairment, gait disturbance, recurrent falls, cognitive deficits and objective abnormalities on imaging, EEG and neuropsychological testing. In January 2023, molecular genetic testing identified a heterozygous nine-octapeptide-repeat insertion in PRNP, also present in her father, confirming Gerstmann–Sträussler–Scheinker disease (GSS). https://pmc.ncbi.nlm.nih.gov/articles/PMC12670835/

Symptoms

Intermittent tremor Dysarthria / speech disturbance Psychomotor slowing / bradykinesia Word-finding difficulty Difficulty constructing sentences Memory impairment Concentration impairment Executive dysfunction Confusion Disorientation Gait disturbance / instability Severe imbalance Recurrent falls Reduced strength in all four limbs Postural tremor Resting tremor Stereotyped upper-limb movements Positive Romberg sign Agitation Restlessness Irritability Mood swings / emotional instability Reduced emotional expressiveness Failure to recognize family members Severe insomnia / sleep disturbance Nocturnal restlessness

Family history

  • Father: developed a similar constellation of symptoms and died prematurely at a relatively young age.
  • Paternal grandmother: also developed similar symptoms and died prematurely at a relatively young age.
  • Patient: only child, no siblings.
  • Genetic testing subsequently showed that both the patient and her father carried the heterozygous 9-OPRI insertion in the PRNP gene
Timeline
8 events
2019-01

Activity for 2019-01

1 event, 0 medicines, 0 lab results, 0 scans
Events
Initial presentation and conversion disorder diagnosis 38 years
2021-11

Activity for 2021-11

1 event, 0 medicines, 0 lab results, 0 scans
Events
Cerebral atrophy appears on CT 40 years
2022-01

Activity for 2022-01

1 event, 0 medicines, 0 lab results, 0 scans
Events
MRI demonstrates cerebral atrophy 41 years
2022-03

Activity for 2022-03

1 event, 0 medicines, 0 lab results, 0 scans
Events
Progressive speech and gait impairment 41 years
2022-06

Activity for 2022-06

3 events, 0 medicines, 0 lab results, 0 scans
Events
Severe cognitive deficits documented 41 years EEG shows encephalopathy 41 years Electroneurography identifies neuropathy 41 years
2023-01

Activity for 2023-01

1 event, 5 medicines, 0 lab results, 0 scans
Events
PRNP testing confirms GSS 42 years
Medicine
Eszopiclone 2 mg Quetiapine XR 200 mg Quetiapine 25 mg Escitalopram 10 mg Valproate
Medicine
1 months
Month Medicines
2023-01
Eszopiclone 2 mg Quetiapine XR 200 mg Quetiapine 25 mg Escitalopram 10 mg Valproate
Lab Results
1 sections

PatientMeta

0 items
Test / Reference Readings Range graph
No items found in this section.
Analysis
0 matches

Single readings that fall outside the reference range.

No matching tests for this analysis mode.
Leave a comment
Open Discussion

All comments are reviewed before being published. A wide range of opinions is allowed, as long as they are relevant and respectful.

Commenting on
Replying to
Uploading image... 0%